Increased levels of hyaluronic acid in cerebrospinal fluid in patients with vascular dementia

Journal of Alzheimer's Disease

Volumn 42, Issue 4, 2014, Pages 1435-1441

  Nägga, Katarina ^a   Hansson, Oskar ^a   Van Westen, Danielle ^b,c   Minthon, Lennart ^a   Wennström, Malin ^a  

^a LUND UNIVERSITY   (Sweden)

^b LUND UNIVERSITY   (Sweden)

^c LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Biomarker; cerebrospinal fluid; glycocalyx; hyaluronic acid; vascular dementia

Indexed keywords

C REACTIVE PROTEIN; HYALURONIC ACID; SERUM ALBUMIN; ALBUMINOID; AMYLOID BETA PROTEIN; AMYLOID BETA-PROTEIN (1-42); BIOLOGICAL MARKER; MAPT PROTEIN, HUMAN; PEPTIDE FRAGMENT; TAU PROTEIN;

AGED; ALZHEIMER DISEASE; ARTICLE; BLOOD BRAIN BARRIER; BRAIN BLOOD VESSEL; BRAIN INFARCTION; CEREBROSPINAL FLUID; CEREBROSPINAL FLUID LEVEL; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DIAGNOSTIC VALUE; FEMALE; GLYCOCALYX; HEAD INJURY; HUMAN; HUMAN TISSUE; IMMUNOASSAY; MAJOR CLINICAL STUDY; MALE; MINI MENTAL STATE EXAMINATION; MULTIINFARCT DEMENTIA; NUCLEAR MAGNETIC RESONANCE IMAGING; WHITE MATTER; BLOOD; BRAIN; METABOLISM; MIDDLE AGED; NEUROPSYCHOLOGICAL TEST; PATHOLOGY; PHOSPHORYLATION;

AGED; ALBUMINS; ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; BIOLOGICAL MARKERS; BRAIN; DEMENTIA, VASCULAR; FEMALE; HUMANS; HYALURONIC ACID; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; PEPTIDE FRAGMENTS; PHOSPHORYLATION; TAU PROTEINS;

EID: 84907972736     PISSN: 13872877     EISSN: 18758908     Source Type: Journal    
DOI: 10.3233/JAD-141200     Document Type: Article

References (38)

1. Fraser JR, Laurent TC, Laurent UB (1997) Hyaluronan: Its nature, distribution, functions and turnover. J Intern Med 242, 27-33.
2. Adamson RH, Lenz JF, Zhang X, Adamson GN, Weinbaum S, Curry FE (2004) Oncotic pressures opposing filtration across non-fenestrated rat microvessels. J Physiology 557, 889-907.
3. Lennon FE, Singleton PA (2011) Hyaluronan regulation of vascular integrity. Am J Cardiovasc Dis 1, 200-213.
4. Mulivor AW, Lipowsky HH (2002) Role of glycocalyx in leukocyte-endothelial cell adhesion. Am J Physiol Heart Circ Physiol 283, H1282-H1291.
5. Kashima Y, Takahashi M, Shiba Y, Itano N, Izawa A, Koyama J, Nakayama J, Taniguchi S, Kimata K, Ikeda U (2013) Crucial role of hyaluronan in neointimal formation after vascular injury. PLoS One 8, e58760.
6. Gao L, Lipowsky HH (2010) Composition of the endothelial glycocalyx and its relation to its thickness and diffusion of small solutes. Microvasc Res 80, 394-401.
7. Nagy N, Freudenberger T, Melchior-Becker A, Rock K, Ter Braak M, Jastrow H, Kinzig M, Lucke S, Suvorava T, Kojda G, Weber AA, Sorgel F, Levkau B, Ergun S, Fischer JW (2010) Inhibition of hyaluronan synthesis accelerates murine atherosclerosis: Novel insights into the role of hyaluronan synthesis. Circulation 122, 2313-2322.
8. Karangelis DE, Kanakis I, Asimakopoulou AP, Karousou E, Passi A, Theocharis AD, Triposkiadis F, Tsilimingas NB, Karamanos NK (2010) Glycosaminoglycansaskeymolecules in atherosclerosis: The role of versican and hyaluronan. Curr Med Chem 17, 4018-4026.
9. Al'Qteishat A, Gaffney J, Krupinski J, Rubio F, West D, Kumar S, Kumar P, Mitsios N, Slevin M (2006) Changes in hyaluronan production and metabolism following ischaemic stroke in man. Brain 129, 2158-2176.
10. Nielsen HM, Palmqvist S, Minthon L, Londos E, Wennstrom M (2012) Gender-dependent levels of hyaluronic acid in cere-brospinal fluid of patients with neurodegenerative dementia. Curr Alzheimer Res 9, 257-266.
11. Manicourt DH, Poilvache P, Nzeusseu A, van Egeren A, Devogelaer JP, Lenz ME, Thonar EJ (1999) Serum levels of hyaluronan, antigenic keratan sulfate, matrix metallopro-teinase 3, and tissue inhibitor of metalloproteinases 1 change predictably in rheumatoid arthritis patients who have begun activity after a night of bed rest. Arthritis Rheum 42, 1861-1869.
12. American Psychiatric Association (1987) Diagnostic and Statistical Manual of Mental Disorder, DSM-III-R. American Psychiatric Association, Washington, DC.
13. McKhann GM, Knopman DS, Chertkow H, Hyman BT, Jack CR Jr, Kawas CH, Klunk WE, Koroshetz WJ, Manly JJ, Mayeux R, Mohs RC, Morris JC, Rossor MN, Scheltens P, Carrillo MC, Thies B, Weintraub S, Phelps CH (2011) The diagnosis of dementia due to Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement 7, 263-269.
14. RománGC, Tatemichi TK, Erkinjuntti T, Cummings JL, Mas-deu JC, Garcia JH, Amaducci L, Orgogozo J-M, Brun A, Hofman A, Moody DM, O'Brien MD, Yamaguchi T, Graf-man J, Drayer BP, Bennett DA, Fisher M, Ogata J, Kokmen E, Bermejo F, Wolf PA, Gorelick PB, Bick KL, Pajeau AK, Bell MA, DeCarli C, Culebras A, Korczyn AD, Bogousslavsky J, Hartmann A, Scheinberg P (1993) Vascular dementia: Diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop. Neurology 43, 250-260.
15. Wahlund LO, Barkhof F, Fazekas F, Bronge L, Augustin M, Sjogren M, Wallin A, Ader H, Leys D, Pantoni L, Pasquier F, Erkinjuntti T, Scheltens P (2001) A new rating scale for age-related white matter changes applicable to MRI and CT. Stroke 32, 1318-1322.
16. Folstein MF, Folstein SE, McHugh PR (1975) Mini-mental state. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12, 189-198.
17. Wennstrom M, Surova Y, Hall S, Nilsson C, Minthon L, Bostrom F, Hansson O, Nielsen HM (2013) Low CSF levels of both alpha-synuclein and the alpha-synuclein cleaving enzyme neurosin in patients with synucleinopathy. PLoS One 8, e53250.
18. Kalaria RN, Ballard C (1999) Overlap between pathology of Alzheimer disease and vascular dementia. Alzheimer Dis Assoc Disord 13 (Suppl 3), S115-S123.
19. Rooney P, Kumar S, Ponting J, Wang M (1995) The role of hyaluronan in tumour neovascularization (review). Int J Cancer 60, 632-636.
20. Bollyky PL, Falk BA, Wu RP, Buckner JH, Wight TN, Nepom GT (2009) Intact extracellular matrix and the maintenance of immune tolerance: High molecular weight hyaluronan promotes persistenceofinduced CD4+ CD25+ regulatoryTcells. J Leukoc Biol 86, 567-572.
21. Girish KS, Kemparaju K (2007) The magic glue hyaluronan and its eraser hyaluronidase: A biological overview. Life Sci 80, 1921-1943.
22. West DC, Hampson IN, Arnold F, Kumar S (1985) Angio-genesis induced by degradation products of hyaluronic acid. Science 228, 1324-1326.
23. Yuan H, Tank M, Alsofyani A, Shah N, Talati N, Lobello JC, Kim JR, Oonuki Y, de la Motte CA, Cowman MK (2013) Molecular mass dependence of hyaluronan detection by sandwich ELISA-like assay and membrane blotting using biotinylated hyaluronan binding protein. Glycobiology 23, 1270-1280.
24. Grammas P, Martinez J, Miller B (2011) Cerebral microvas-cular endothelium and the pathogenesis of neurodegenerative diseases. Expert Rev Mol Med 13, e19.
25. Zeng Y, Ebong EE, Fu BM, Tarbell JM (2012) The structural stability of the endothelial glycocalyx after enzymatic removal of glycosaminoglycans. PLoS One 7, e43168.
26. Fagan AM, Shaw LM, Xiong C, Vanderstichele H, Mintun MA, Trojanowski JQ, Coart E, Morris JC, Holtzman DM (2011) Comparison of analytical platforms for cerebrospinal fluid measures of beta-amyloid 1-42, total tau, and p-tau181 for identifying Alzheimer disease amyloid plaque pathology. Arch Neurol 68, 1137-1144.
27. Biron KE, Dickstein DL, Gopaul R, Jefferies WA (2011) Amyloid triggers extensive cerebral angiogenesis causing blood brain barrier permeability and hypervascularity in Alzheimer's disease. PLoS One 6, e23789.
28. Ujiie M, Dickstein DL, Carlow DA, Jefferies WA (2003) Blood-brain barrier permeability precedes senile plaque formation in an Alzheimer disease model. Microcirculation 10, 463-470.
29. Biron KE, Dickstein DL, Gopaul R, Fenninger F, Jefferies WA (2013) Cessation of neoangiogenesis in Alzheimer's disease follows amyloid-beta immunization. Sci Rep 3, 1354.
30. Dickstein DL, Biron KE, Ujiie M, Pfeifer CG, Jeffries AR, Jefferies WA (2006) Abeta peptide immunization restores blood-brain barrier integrity in Alzheimer disease. FASEB J 20, 426-433.
31. Zand L, Ryu JK, McLarnon JG (2005) Induction of angio-genesisinthe beta-amyloid peptide-injected rat hippocampus. Neuroreport 16, 129-132.
32. Boscolo E, Folin M, Nico B, Grandi C, Mangieri D, Longo V, Scienza R, Zampieri P, Conconi MT, Parnigotto PP, Ribatti D (2007) Beta amyloid angiogenic activity in vitro and in vivo. Int J Mol Med 19, 581-587.
33. Cantara S, Donnini S, Morbidelli L, Giachetti A, Schulz R, Memo M, Ziche M (2004) Physiological levels of amyloid peptides stimulate the angiogenic response through FGF-2. FASEB J 18, 1943-1945.
34. Cantara S, Ziche M, Donnini S (2005) Opposite effects of beta amyloid on endothelial cell survival: Role of fibroblast growth factor-2 (FGF-2). Pharmacol Rep 57 Suppl, 138-143.
35. Sadowitz B, Seymour K, Gahtan V, Maier KG (2012) The role of hyaluronic acid in atherosclerosis and intimal hyperplasia. J Surg Res 173, e63-e72.
36. Duron E, Hanon O (2008) Vascular risk factors, cognitive decline, and dementia. Vasc Health Risk Manag 4, 363-381.
37. Bos D, Ikram MA, Elias-Smale SE, Krestin GP, Hofman A, Witteman JC, van der Lugt A, Vernooij MW (2011) Calcification in major vessel beds relates to vascular brain disease. Arterioscler Thromb Vasc Biol 31, 2331-2337.
38. Bos D, Vernooij MW, Elias-Smale SE, Verhaaren BF, Vrooman HA, Hofman A, Niessen WJ, Witteman JC, van der Lugt A, Ikram MA (2012) Atherosclerotic calcification relates to cognitive function and to brain changes on magnetic resonance imaging. Alzheimers Dement 8, S104-S111.